---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-024559"
form_type: "8-K"
ticker: "TMCI"
cik: "0001630627"
company_name: "TREACE MEDICAL CONCEPTS, INC."
filed_at: "2023-05-26T23:59:59+00:00"
generated_at: "2026-06-14T13:05:15.632284+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Treace Medical Concepts stockholders elect three Class I directors, ratify Grant Thornton as auditor

## Summary
- Lance A. Berry, Elizabeth Hanna, and Jane E. Kiernan elected to Class I board for term expiring 2025; Berry received 49.8M for, Hanna 39.9M for, Kiernan 49.8M for.
- Grant Thornton LLP ratified as independent auditor for fiscal year ending Dec 31, 2023: 56,651,839 for, 5,348 against, 29,343 abstain.
- Broker non-votes: 4,279,391 on director elections; none on auditor ratification.

## SEC filing metadata
- accession: 0000950170-23-024559
- form_type: 8-K
- ticker: TMCI
- cik: 0001630627
- company_name: TREACE MEDICAL CONCEPTS, INC.
- filed_at: 2023-05-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630627/000095017023024559/0000950170-23-024559-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630627/000095017023024559/tmci-20230523.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-024559
- JSON: https://secwatch.observer/filing/0000950170-23-024559.json
- Plain text: https://secwatch.observer/filing/0000950170-23-024559.txt

## Key facts
- Shareholder Votes
  TREACE MEDICAL CONCEPTS, INC. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-05-23 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-23
  source text: The stockholders ratified, by the votes indicated below, the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000095017023024559/0000950170-23-024559-index.htm
- Shareholder Votes
  TREACE MEDICAL CONCEPTS, INC. shareholders approved Election of Class I Directors at the 2023-05-23 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-23
  source text: The stockholders elected, by the votes indicated below, the following nominees to the Company’s Board of Directors to serve as Class I directors for a three-year term of office expiring at the 2025 annual meeting of the stockholders or until their respective successors have been duly elected and qualified:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000095017023024559/0000950170-23-024559-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.